ADVERTISEMENTs

New app aims to predict epileptic seizures

The founders aim to mitigate the risk of injuries caused by sudden seizures and improve the quality of life for individuals with epilepsy.

Simran Lallian, left, and Jaya Athuluru / (Gregory Urquiaga/UC Davis)

Two University of California, Davis undergraduates, Simran Lallian and Jaya Athuluru, have launched EpiSense, a medtech startup aimed at predicting epileptic seizures using an electroencephalogram (EEG) and machine learning. 

Their innovation seeks to mitigate the risk of injuries caused by sudden seizures and improve the quality of life for individuals with epilepsy.

Also Read: AI can identify women at risk of breast cancer years in advance: study

The startup’s wearable device integrates EEG technology with a mobile app to provide advance warning of impending seizures, giving users crucial moments to move to safety and prevent injuries. The app also allows for real-time alerts to designated contacts and emergency services while storing seizure activity data for medical use.

Athuluru, who was diagnosed with epilepsy in middle school, highlighted the personal connection to their work. “I was diagnosed with epilepsy in middle school, so it was a very near and dear disorder to us,” she said. Lallian and Athuluru met through Neurotech@Davis, a student organization focused on neuroscience and technology, where they discovered a shared interest in medical innovation and entrepreneurship.

Their journey began in fall 2023 when they won a prize in the UC Davis campus round of the Blackstone LaunchPad Ideas Competition, eventually securing a $10,000 prize in the national competition. EpiSense won first prize at the 2024 Big Bang! Business Competition, securing a $25,000 award. They also earned recognition in the Little Bang! Pitch and Poster Competition and won the Plasma Demo Day competition, receiving an additional $10,000 in funding.

Joanna Siebert, associate director of the Institute for Innovation and Entrepreneurship, commended their efforts. “The EpiSense team demonstrated a strong commitment to addressing a complex issue that affects millions of people. Their enthusiasm has also inspired others to explore innovation and entrepreneurship,” she said.

The EpiSense team plans to use their prize money for prototyping, refining their software and app, conducting clinical trials, and eventually seeking FDA approval. Their broader goal is to bring their device to market and improve epilepsy management.

Other members of the EpiSense team include Nicole Chen (neurobiology, physiology, and behavior), Zubaira Amin (cognitive science), Suvan Sudan (mechanical engineering), Mihir Juneja (electrical engineering), Shivam Bhandari (computer science), and Aditya Sharma (computer science and engineering).

Lallian is a second-year neurobiology, physiology, and behavior major, while Athuluru is a third-year neurological cognitive science major at UC Davis.

Comments